ArticleLeukemia2009

The TLR1/2 agonist PAM(3)CSK(4) instructs commitment of human hematopoietic stem cells to a myeloid cell fate.

K De Luca et al.PubMed ↗Publisher ↗

No numbers read from the abstract.